Cargando…
Therapeutic potential of single-nucleotide polymorphism-mediated interleukin-6 receptor blockade in cancer treatment: A Mendelian randomization study
BACKGROUND: Interleukin-6 (IL-6) is a crucial member of the cytokine network and plays a pivotal role in the pathogenesis of various diseases, including cancer. IL-6 receptor (IL-6R) blockade is widely employed as a therapeutic strategy; however, its efficacy in anticancer therapy remains ambiguous....
Autores principales: | Zhang, Shuwan, Zhang, Wenchuan, Sun, Hanxue, Xue, Rui, Lv, Qingjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556766/ https://www.ncbi.nlm.nih.gov/pubmed/37810867 http://dx.doi.org/10.1016/j.heliyon.2023.e20474 |
Ejemplares similares
-
Mendelian randomization analysis revealed a gut microbiota–mammary axis in breast cancer
por: Zhang, Shuwan, et al.
Publicado: (2023) -
Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization
por: Li, Shuxuan, et al.
Publicado: (2022) -
Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients
por: Chen, Dawei, et al.
Publicado: (2013) -
Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes
por: WANG, ZHAOWEN, et al.
Publicado: (2016) -
An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population
por: Abbasabad, Ghader Dargahi, et al.
Publicado: (2018)